Free Data on Zimmer Hldgs
Stock Symbol: ZMH
|Receive a complete Daily History of this Stock
You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file
in ASCII format within a few hours or ordering.
Product Details | Order
Zimmer Holdings, Inc. designs, develops, manufactures and markets orthopaedic reconstructive implants, fracture management products and other products used for orthopaedic and general surgery. The Company has operations in 20 countries and markets products in 70 countries, with headquarters in Warsaw, Indiana, and manufacturing, distribution and warehousing and/or office facilities in more than 50 locations worldwide. Orthopaedic reconstructive implants restore joint function lost due to disease or trauma in joints, such as knees, hips, shoulders and elbows. Fracture management products are devices used primarily to reattach or stabilize damaged bone or tissue to support the body's natural healing process. Zimmer also manufactures and markets orthopaedic surgical products, including surgical supplies and instruments designed to aid in orthopaedic surgical procedures. The Company was incorporated as a wholly owned subsidiary of Bristol-Myers Squibb Company.
Zimmer Holdings, Inc. is engaged in the design, development, manufacturing and marketing of orthopaedic reconstructive implants and fracture management products, including artificial knees, hips and other joints. For the six months ended 6/30/02, net sales rose 15% to $664.7 million. Net income rose 52% to $120.5 million. Results reflect increased sales in the Americas due to strong demand for reconstructive implants and higher margins due to higher average prices.